TCL Archive Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research September 13, 1996
TCL Archive Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview) May 16, 2003
TCL Archive Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease June 29, 2012
TCL Archive Also in this 8-page issue: Use cancer mortality, not 5-year survival, to track progress against cancer, researchers say. July 29, 2005
